Upstate Active Clinical Trials
Study Title:A randomized, open-label, phase II study of canakinumab or pembrolizumab as monotherapy or in combination as neoadjuvant therapy in subjects with resectable non-small cell lung cancer (CANOPY-N)
Upstate Institutional Review Board (IRB) Number:1476715
Patient Age Group:Adults
Principal Investigator:Stephen L Graziano, MD
What is involved if I participate?
- Is transportation provided or reimbursed?
- Is parking provided or reimbursed?
Who can I contact for more information?
Name: Eunice B Awuah, PhD